EGFR and non-small cell lung carcinoma: Indeed, EVs from the CRL-2868 non-small cell lung cancer (NSCLC) cell line and from lung cancer patients contain Amphiregulin (AREG) which in turn promotes osteoclast differentiation and exacerbated bone resorption by an EGFR-dependent mechanism (56).